Health Products

ACT Losartan / HCT (2017-09-01)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: Healthcare Professionals, General Public, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
K50626
Recalling Firm
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
ACT Losartan / HCTTablet0238827812.5mg - Hydrochlorothiazide

Introduction

Affected products

ACT Losartan / HCT

Reason

Out of specification for Hydrochlorothiazide assay in affected lot

Depth of distribution

wholesalers and retailers, including pharmacies within Canada
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime